TP53 and colorectal carcinoma: Moreover, SW480 and DLD-1 cell lines with depleted mutant p53 were as sensitive as their parental cells to PRIMA-1Met treatment, demonstrating that PRIMA-1Met could suppress CRC cell growth in a p53-independent manner.